This federal contract award to Pacific Biosciences of California, Inc. is a delivery order under an Indefinite Delivery Indefinite Quantity (IDIQ) contract #75F40121D00007 with the Food and Drug Administration (FDA). The purpose is to purchase specific supplies and reagents for the PacBio Sequel IIe long-read DNA/RNA sequencer. The award is for a firm fixed-price of $46,341.66, with a period of performance through May 30, 2025.
Pacific Biosciences is the original equipment manufacturer for the Sequel and Sequel II sequencing platforms, which are utilized by various federal agencies to support genomic research and regulatory activities. This award is part of a $1 million single-award IDIQ contract the company holds with the FDA for the provision of sequencing reagents, kits, and consumables through March 2025. The contract does not have a set-aside designation, reflecting Pacific Biosciences' unique position as the sole supplier of their proprietary long-read sequencing technology to the government.
Generated 3/19/25, 9:45 AM